Analgesic tolerance without demonstrable opioid-induced hyperalgesia: a double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain
- PMID: 22704854
- DOI: 10.1016/j.pain.2012.02.028
Analgesic tolerance without demonstrable opioid-induced hyperalgesia: a double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain
Abstract
Although often successful in acute settings, long-term use of opioid pain medications may be accompanied by waning levels of analgesic response not readily attributable to advancing underlying disease, necessitating dose escalation to attain pain relief. Analgesic tolerance, and more recently opioid-induced hyperalgesia, have been invoked to explain such declines in opioid effectiveness over time. Because both phenomena result in inadequate analgesia, they are difficult to distinguish in a clinical setting. Patients with otherwise uncomplicated low-back pain were titrated to comfort or dose-limiting side effects in a prospective, randomized, double-blind, placebo-controlled clinical trial using sustained-release morphine or weight-matched placebo capsules for 1 month. A total of 103 patients completed the study, with an average end titration dose of 78 mg morphine/d. After 1 month, the morphine-treated patients developed tolerance to the analgesic effects of remifentanil, but did not develop opioid-induced hyperalgesia. On average, these patients experienced a 42% reduction in analgesic potency. The morphine-treated patients experienced clinically relevant improvements in pain relief, as shown by a 44% reduction in average visual analogue scale pain levels and a 31% improvement in functional ability. The differences in visual analogue scale pain levels (P = .003) and self-reported disability (P = .03) between both treatment groups were statistically significant. After 1 month of oral morphine therapy, patients with chronic low-back pain developed tolerance but not opioid-induced hyperalgesia. Improvements in pain and functional ability were observed.
Copyright © 2012 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
Comment in
-
Tolerance and opioid-induced hyperalgesia. Is a divorce imminent?Pain. 2012 Aug;153(8):1547-1548. doi: 10.1016/j.pain.2012.05.002. Epub 2012 May 17. Pain. 2012. PMID: 22608577 No abstract available.
Similar articles
-
Evolution of Analgesic Tolerance and Opioid-Induced Hyperalgesia Over 6 Months: Double-Blind Randomized Trial Incorporating Experimental Pain Models.J Pain. 2020 Sep-Oct;21(9-10):1031-1046. doi: 10.1016/j.jpain.2020.01.005. Epub 2020 Feb 1. J Pain. 2020. PMID: 32006699 Clinical Trial.
-
Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study.J Pain. 2006 Jan;7(1):43-8. doi: 10.1016/j.jpain.2005.08.001. J Pain. 2006. PMID: 16414554 Clinical Trial.
-
Tolerance and opioid-induced hyperalgesia. Is a divorce imminent?Pain. 2012 Aug;153(8):1547-1548. doi: 10.1016/j.pain.2012.05.002. Epub 2012 May 17. Pain. 2012. PMID: 22608577 No abstract available.
-
Pain management in the opioid-dependent patient.Curr Psychiatry Rep. 2001 Dec;3(6):489-96. doi: 10.1007/s11920-001-0043-9. Curr Psychiatry Rep. 2001. PMID: 11707163 Review.
-
Chronic Cancer Pain: Opioids within Tumor Microenvironment Affect Neuroinflammation, Tumor and Pain Evolution.Cancers (Basel). 2022 Apr 30;14(9):2253. doi: 10.3390/cancers14092253. Cancers (Basel). 2022. PMID: 35565382 Free PMC article. Review.
Cited by
-
Opioids for chronic pain.CMAJ. 2018 Mar 5;190(9):E269. doi: 10.1503/cmaj.68954. CMAJ. 2018. PMID: 29507160 Free PMC article. No abstract available.
-
Assessment of morphine-induced hyperalgesia and analgesic tolerance in mice using thermal and mechanical nociceptive modalities.J Vis Exp. 2014 Jul 29;(89):e51264. doi: 10.3791/51264. J Vis Exp. 2014. PMID: 25145878 Free PMC article.
-
Between guidelines and clinical trials: evidence-based advice on the pharmacological management of non-specific chronic low back pain.BMC Musculoskelet Disord. 2023 May 30;24(1):432. doi: 10.1186/s12891-023-06537-0. BMC Musculoskelet Disord. 2023. PMID: 37254090 Free PMC article. Review.
-
Mediating Effect of Pain Sensitization on the Paradoxical Relation of Taking Opioids to Pain Severity in Knee Osteoarthritis: The Multicenter Osteoarthritis Study.Arthritis Care Res (Hoboken). 2024 Mar;76(3):403-408. doi: 10.1002/acr.25244. Epub 2023 Dec 28. Arthritis Care Res (Hoboken). 2024. PMID: 37750238 Free PMC article.
-
Differential tolerance to morphine antinociception in assays of pain-stimulated vs. pain-depressed behavior in rats.Eur J Pharmacol. 2015 Feb 5;748:76-82. doi: 10.1016/j.ejphar.2014.12.011. Epub 2014 Dec 18. Eur J Pharmacol. 2015. PMID: 25530266 Free PMC article.
References
-
- Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006;104:570-587.
-
- Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain. 2003;106:49-57.
-
- Angst MS, Ramaswamy B, Riley ET, Stanski DR. Lumbar epidural morphine in humans and supraspinal analgesia to experimental heat pain. Anesthesiology. 2000;92:312-324.
-
- Beck A, Steer R, Carbin M. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77-100.
-
- Chia YY, Liu K, Wang JJ, Kuo MC, Ho ST. Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can J Anaesth. 1999;46:872-877.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical